Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) - The Diagnostic Problem (CROSBI ID 562744)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Borovečki, Ana ; Jelić-Puškarić, Biljana ; Džebro, Sonja ; Kardum-Skelin, Ika Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) - The Diagnostic Problem // Knjiga sažetaka, 4. Hrvatski kongres kliničke citologije, 1. Hrvatski simpozij analitičke citologije i 2. Hrvatski simpozij citotehnologije s međunarodnim sudjelovanjem / Kardum-Skelin, Ika ; Batinić, Drago ; Anić, Veronika (ur.). Zagreb: Hrvatsko društvo za kliničku citologiju ; Hrvatska udruga citotehnologa, 2009

Podaci o odgovornosti

Borovečki, Ana ; Jelić-Puškarić, Biljana ; Džebro, Sonja ; Kardum-Skelin, Ika

engleski

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) - The Diagnostic Problem

NLPHL represents 5% of all HL. Compared with CHL, NLPHL shows a slightly older median age at presentation (med. 37), male predominance and localized peripheral lymphadenopathy with less mediastinal involvement (<15%). Neoplastic LP (L&H or “popcorn”) cells of GCB origin express B-cell associated antigens, are embedded in background of progressively transformed follicles which contain FDC networks, small B and T lymphocytes many of which are CD4+/CD57+ that surround LP cells. Aim: Because NLPHL shares morphologic and immunophenotypic characteristics with THRLBCL, CHL, DLBCL, ALCL and PTGC we analyze the possibility to diagnose NLPHL in lymph node (LN) aspirates. Patients and methods: In period 2005–2009, 11 patients with NLPHL were diagnosed in LN biopsies samples, using following markers CD20, CD3, CD4, CD8, CD21, CD30, CD15, CD57, CD68, EBV-LMP, TIA-1, PAX5, EMA, ALK. The LN aspiration biopsy was performed in all patients as first morphological approach and following markers CD20, CD3, CD30, CD15, EMA, ALK were used. Results: The cytology diagnoses were: HL (1/11) ; CHL (1/11), LN biopsy diagnosis on previously extirpated, another LN was reactive hyperplasia ; HL, ALCL? (1/11) ; NHL pleomorphic type, ALCL? (1/11) ; NHL (3/11) ; NHL MALT (1/11) ; granulomatous lesion, NHL? (1/11) ; bad preserved neoplastic cells, origin? (1/11) ; lymph node reactive hyperplasia with some atypical, reticular cells (1/11). Conclusion: The diversity of differential diagnoses indicates the NLPHL as a diagnostic problem. The immunophenotype of small lymphocytes in lymph node smears was not determinate. Also the clonal IgH rearrangements are usually not detectable in whole tissue DNA with flow cytometry and PCR, although NLPHL is a monoclonal B-cell neoplasm. To confirm NLPHL diagnosis the clonal IgH rearrangements are detectable only in the DNA of isolated single LP cells by microdissection.

NLPHL; CHL

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2009.

objavljeno

Podaci o matičnoj publikaciji

Knjiga sažetaka, 4. Hrvatski kongres kliničke citologije, 1. Hrvatski simpozij analitičke citologije i 2. Hrvatski simpozij citotehnologije s međunarodnim sudjelovanjem

Kardum-Skelin, Ika ; Batinić, Drago ; Anić, Veronika

Zagreb: Hrvatsko društvo za kliničku citologiju ; Hrvatska udruga citotehnologa

Podaci o skupu

4. Hrvatski kongres kliničke citologije, 1. Hrvatski simpozij analitičke citologije i 2. Hrvatski simpozij citotehnologije s međunarodnim sudjelovanjem

predavanje

11.10.2009-14.10.2009

Split, Hrvatska

Povezanost rada

Kliničke medicinske znanosti